Daniel Malamud

Corporate Officer/Principal at NYU College of Dentistry

Consumer Services

Health Services

Profile

Daniel Malamud is the founder of TB Biosciences, Inc. which was founded in 2013.
He is currently a Professor at New York University School of Medicine and NYU College of Dentistry.

Daniel Malamud active positions

Companies	Position	Start
NYU College of Dentistry	Corporate Officer/Principal	-
New York University School of Medicine	Corporate Officer/Principal	-

All active positions of Daniel Malamud

Former positions of Daniel Malamud

Companies	Position	End
TB Biosciences, Inc. TB Biosciences, Inc. Medical/Nursing ServicesHealth Services TB Biosciences, Inc. operates as a early stage development medical diagnostics company which develops a rapid point-of-care tuberculosis tests. It uses key peptides to detect antibodies in patients with active tuberculosis derived from the genome of the tuberculosis organism, thus offering a completely new approach to testing. The firm is using an array of patented peptides developed and exclusively licensed from the New York university school of medicine. The company was founded by Daniel Malamud, Susan Zolla-Pazner, Suman Laal, R. Sam Niedbala and William Abrams in May 2013 and is headquartered in Bethlehem, PA.	Founder	-

See the detail of Daniel Malamud's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Malamud's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
TB Biosciences, Inc. TB Biosciences, Inc. Medical/Nursing ServicesHealth Services TB Biosciences, Inc. operates as a early stage development medical diagnostics company which develops a rapid point-of-care tuberculosis tests. It uses key peptides to detect antibodies in patients with active tuberculosis derived from the genome of the tuberculosis organism, thus offering a completely new approach to testing. The firm is using an array of patented peptides developed and exclusively licensed from the New York university school of medicine. The company was founded by Daniel Malamud, Susan Zolla-Pazner, Suman Laal, R. Sam Niedbala and William Abrams in May 2013 and is headquartered in Bethlehem, PA.	Health Services